Vaccine patent waiver: COVID stopper or innovation killer?

Five things to know about India's proposal, US support and China's chance to gain

20210514 vaccine closed

An Indian policeman asks people who came for COVID-19 vaccine shots to leave due to exhausted supplies in Mumbai on May 3. © Reuters

AKANE OKUTSU and KIRAN SHARMA, Nikkei staff writers

TOKYO/NEW DELHI -- The U.S. earlier this month said it supports temporarily waiving intellectual property protections on COVID-19 vaccines. In doing so, President Joe Biden's administration threw serious weight behind a proposal brought to the World Trade Organization by India and South Africa.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.